PHG

Koninklijke Philips
D

PHG

Arincen44/100B

Koninklijke Philips financials

Yes. Koninklijke Philips earned 956.84M EUR of net income over the last twelve months, 5.4% of its revenue. It made a profit in 29 of its 39 fiscal years since 1987. Its last loss was in fiscal year 2024.

Revenue (TTM)
17.73B EUR
Net income (TTM)
956.84M EUR
Free cash flow (TTM)
2.11B EUR
Cash and short-term investments
2.80B EUR
Total debt
8.28B EUR
Shareholders' equity
11.78B EUR

Cash, debt and equity as of 30 Sept 2026.

Koninklijke Philips earnings

Next earnings · Q4 FY2026
EPS estimate
0.65 USD
Revenue estimate
6.04B USD
Last quarter · Q3 FY2026
EPS0.46Beat +24.3%Revenue4.93BMissed -1.6%

Revenue

ReportedEstimate

EPS

ReportedEstimate
PeriodReport dateEPS estimateReported EPSSurpriseEPS growthRevenue estimateReported revenueSurpriseRevenue growth
Q4 FY20260.65——-7.14%6.04B——-0.55%
Q3 FY20260.370.46+24.32%+24.32%5.01B4.93B-1.63%-2.25%
Q2 FY20260.400.57+42.50%+39.02%4.91B4.96B+1.19%-2.81%
Q1 FY20260.240.27+12.50%0.00%4.49B4.59B+2.19%-1.25%
Q4 FY20250.570.70+23.89%+29.63%5.89B6.07B+3.12%+16.27%
Q3 FY20250.370.370.00%+5.71%5.03B5.04B+0.12%+4.96%
Q2 FY20250.320.41+29.17%+28.13%4.30B5.11B+18.67%+6.46%

Koninklijke Philips growth and profitability

Full income statement
Revenue (TTM)
17.73B EUR
Net income (TTM)
956.84M EUR
Gross margin
46.43%
Operating margin
10.50%
Net margin
5.40%

Revenue / Net income

Revenue Net income Net margin
PeriodRevenueGrowthNet incomeGrowthGross marginOperating marginNet marginEBITDAGrowth
FY202517.83B-1.04%895.00M—45.18%7.98%5.02%2.64B+42.74%
FY202418.02B-0.81%-702.00M—43.13%2.94%-3.90%1.85B+77.62%
FY202318.17B+1.92%-466.00M—40.99%-0.63%-2.56%1.04B+805.22%
FY202217.83B+3.91%-1.61B-148.45%40.35%-8.58%-9.02%115.00M-94.24%
FY202117.16B-0.91%3.32B+179.61%41.78%3.22%19.35%2.00B-36.57%

How Koninklijke Philips makes its money

Revenue17.83B 100.0%
Cost of revenue9.78B 54.8%
Gross profit8.06B 45.2%
Research and development1.70B 9.5%
Selling and administration4.97B 27.9%
Operating income1.42B 8.0%
Tax282.00M 1.6%
Other expense247.00M 1.4%
Net income895.00M 5.0%

FY2025, in EUR. Each band is as wide as its money; the percentage is its share of revenue.

Koninklijke Philips revenue breakdown

By region

FY2025
United States: 40.0%Other countries: 30.4%Netherlands: 14.3%China: 6.7%Japan: 5.0%Germany: 3.7%40.0%United States30.4%Other countries14.3%Netherlands6.7%China5.0%Japan3.7%Germany
RegionRevenueShare of revenueChange on the year
United States7.13B40.0%-1.3%
Other countries5.42B30.4%-3.1%
Netherlands2.55B14.3%+1.6%
China1.20B6.7%+4.2%
Japan883.00M5.0%-0.3%
Germany652.00M3.7%-0.2%

Operating and free cash flow

Full cash flow statement
Operating cash flow Free cash flow
Fiscal yearOperating cash flowFree cash flow
FY20251.16B893.00M
FY20241.70B1.35B
FY20232.31B1.94B
FY2022-181.82M-648.45M
FY20211.93B1.46B
FY20202.64B2.16B
FY20192.27B1.69B
FY20181.78B937.00M
FY20171.87B1.01B
FY20161.90B1.04B

Koninklijke Philips financial health

Full balance sheet
Cash and short-term investments
2.80B EUR
Total debt
8.28B EUR
Net cash
-5.48B EUR
Free cash flow (TTM)
2.11B EUR
Current ratio
1.33
Debt to equity
0.70
Piotroski score
7 / 9
Altman Z-score
2.08

Cash, debt and free cash flow

Cash and short-term investments Total debt Free cash flow
Fiscal yearCash and short-term investmentsTotal debtFree cash flow
FY20252.79B8.09B893.00M
FY20242.40B7.49B1.35B
FY20231.87B7.29B1.94B
FY20221.18B7.34B-648.45M
FY20212.31B6.05B1.46B

Assets, liabilities and equity

Total assets Total liabilities Shareholders' equity
Fiscal yearTotal assetsTotal liabilitiesShareholders' equity
FY202526.94B15.96B10.96B
FY202428.98B16.93B12.01B
FY202329.41B17.35B12.03B
FY202230.69B17.41B13.25B
FY202130.96B16.49B14.44B
FY202027.71B15.81B11.87B
FY201927.02B14.39B12.60B
FY201826.02B13.90B12.09B
FY201725.32B13.29B12.00B
FY201632.30B18.80B12.60B

Koninklijke Philips valuation

Price to earnings ratio (TTM)
27.29
Forward P/E (FY2026)
16.26
Price to sales (TTM)
1.50
Price to book
2.26
EV / EBITDA (TTM)
10.23

Capital structure

Market capitalization
29.66B USD
+
Total debt
9.23B USD
−
Cash and short-term investments
3.12B USD
=
Enterprise value
35.77B USD

Valuation over time

P/EForward P/EForward P/E · EstimateEstimate
Fiscal yearP/EForward P/EP/SP/BEV/EBITDA
FY2027 (est.)16.10————
FY2026 (est.)16.2616.10———
Now (TTM)27.2916.121.502.2610.23
FY202524.2613.781.242.0210.41
FY2024-32.6011.811.271.9015.10
FY2023-41.6511.811.071.6123.81
FY2022-8.339.980.751.01169.60
FY202144.7738.861.591.8915.51

Koninklijke Philips against its own history

Each figure in the latest fiscal year against the same figure from FY2021 to FY2025: the range, its median (the line) and the latest (the dot, green on the good side of the median). The P/E is today's against its daily readings of five years.

Its peers: DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings, Edwards Lifesciences, Boston Scientific, and Glaukos, the US Medical - Devices companies closest to it in size, each in its own latest fiscal year: their median (the line) and its rank among them, first being the best.

  • Gross marginHighest in 5 years45.2%
    40.4%45.2%
    Against its peers: 6 of 7Peers' median 65.3%
  • Operating marginHighest in 5 years8.0%
    -8.6%8.0%
    Against its peers: 6 of 7Peers' median 18.1%
  • Net marginAbove its median5.0%
    -9.0%19.3%
    Against its peers: 6 of 7Peers' median 12.2%
  • Return on equityAbove its median8.2%
    -12.1%23.0%
    Against its peers: 5 of 7Peers' median 11.1%
  • Free cash flow marginBelow its median5.0%
    -3.6%10.7%
    Against its peers: 6 of 7Peers' median 18.1%
  • Revenue growthLowest in 5 years-1.0%
    -1.0%3.9%
    Against its peers: 7 of 7Peers' median 13.6%
  • Debt to EBITDABelow its median3.06×
    3.03×63.84×
    Against its peers: 5 of 6Peers' median 2.43×
  • Current ratioAbove its median1.32
    1.201.39
    Against its peers: 6 of 7Peers' median 1.93

Peers: US companies of the same industry (of its sector when the industry has too few) from a tenth to ten times its market value, the six closest in size. Updated weekly.

Koninklijke Philips dividends

Annual dividend
0.99 USD
Dividend yield (indicated)
3.26%
Payout ratio
89.03%
Years of dividend growth
2
Frequency
Annual
Last payment
0.99 USD
Last ex-dividend date
13 May 2026
Last payment date
3 Jun 2026

Dividends per share

Year2025202420222021202020192018201720162015
Dividends per share0.970.920.961.030.800.960.990.860.880.91

Koninklijke Philips ownership

Institutions
5.40%
Institutional holders
377 (+24)
Free float
99.96%

Who owns the shares

Institutions 5.4% Others 94.6%
As of 30 Jun 2026

Shares free to trade

Free float 976.99M shares ·100.0% Closely held 439.36K shares ·0.0%

Closely held shares belong to insiders, founders and owners of more than 5%, and seldom change hands. The free float is the rest: the shares anyone can buy and sell.

Shares outstanding

Basic shares Diluted shares Change in diluted shares
Fiscal yearBasic sharesDiluted sharesChange in diluted shares
FY2025962.37M962.50M+3.12%
FY2024933.37M933.37M-1.62%
FY2023948.79M948.79M-0.39%
FY2022952.46M952.46M+0.23%
FY2021907.46M950.28M-0.76%

Common questions about Koninklijke Philips's financials

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.